PRIVISCL
Privi Speciality Chemicals share price & financials
- Price
- ₹3,676.5
- Market cap
- ₹14.1k Cr
- Sector
- Chemicals
- Calls analysed
- 6
Privi Speciality Chemicals Limited Q1 FY27
What went well
- Consolidated total income grew 20.01% YoY to ₹681.42 crores (Narayan S. Iyer, page 5).
- PAT increased to ₹83.2 crores from ₹61.46 crores in Q1 FY26 (Narayan S. Iyer, page 5).
- EBITDA margins at 24.58% for Q1 FY27, expected to sustain at ~25% (Narayan S. Iyer, page 5, Sanjeev Patil, page 7).
What to watch
- Gross margin compressed by 650 basis points YoY, from 51% in Q1 FY26 to 44.2% in Q1 FY27 (Vivek Rakholiya, page 6).
What Privi Speciality Chemicals Limited does
Privi Speciality Chemicals is India's largest manufacturer and exporter of aroma chemicals, producing pine-based and specialty ingredients used in fragrances, home care, personal care and other consumer applications. It operates two integrated manufacturing plants at Mahad (Maharashtra) and Jhagadia (Gujarat), backward-integrated into processing Crude Sulphate Turpentine (CST) and Gum Turpentine Oil (GTO) sourced from pulp mills and pine sources worldwide. Its 75+ product portfolio is sold to fragrance-and-flavour and FMCG customers across 40+ countries, and includes PRIGIV, a 51:49 joint venture with Swiss fragrance major Givaudan that manufactures specialty molecules exclusively for its JV partner at the Mahad site. Two dedicated R&D centres, at Mahad and Nerul, staffed by a 114-member scientific team, support new-product development and process innovation.
Segments
- Fragrance
- Home Care
- Personal Care
- Others
- Manufacturing plants
- 2 integrated facilities (Mahad, Maharashtra & Jhagadia, Gujarat)
- Installed production capacity
- 48,000 MTPA
- CST processing capacity
- 36,000 MTPA
- GTO processing capacity
- 12,000 MTPA
- Product portfolio
- 75+ aroma chemical products
- R&D centres
- 2 centres (Mahad & Nerul) with a 114-member R&D team
Guidance record · Q1 FY27
what the last two calls moved 16 tracked 5 delivered 0 missed 11 open- Production Capacity delayed said Q4 FY25 Promised: expand from 48,000 MT to 54,000 MT by March 2026 Q1 FY27: Timeline for 6,000 MT expansion (to 54k MT) pushed from June 2026 to September 2026.
- Revenue & EBITDA Target on track said Q1 FY26 Promised: Rs. 5,000 crores revenue and Rs. 1,000 crore EBITDA in the next 3-5 years Q1 FY27: Vision of Rs. 5,000 crores revenue and Rs. 1,000 crores+ EBITDA in next 3-4 years reiterated.
- Revenue Growth delivered said Q4 FY25 Promised: minimum try to maintain our average growth rate of 20% to 25% Q4 FY26: FY26 revenue grew 21.73% YoY, meeting the target range.
All 16 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue up 19.1%, net profit up 43.1% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 533 | 491 | 614 | 559 | 679 +27% | 605 +23% | 722 +18% | 666 +19% |
| EBITDA | 110 | 113 | 133 | 132 | 182 +65% | 151 +34% | 180 +35% | 152 +15% |
| Net profit | 45 | 44 | 64 | 58 | 90 +100% | 75 +70% | 94 +47% | 83 +43% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +52.3% 1Y
1Y: ₹2,335 on 10 Sept 2025 → ₹3,556.1. High ₹3,750.8 (2 Jul 2026), low ₹2,331.6 (11 Sept 2025).
How the price took the results
close before → close after
- Q1 FY27
- +1.2%
- 31 Jul
- Q4 FY26
- −9.0%
- 12 May
- Q3 FY26
- −0.5%
- 10 Feb
- Q2 FY26
- +3.3%
- 7 Nov
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
Revenue grew 16.8% a year over 3 years, FY23 to FY26. Operating margin widened to 25.1%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹1.6k Cr | ₹1.8k Cr | ₹2.1k Cr | ₹2.6k Cr |
| Operating profit | ₹186 Cr | ₹325 Cr | ₹450 Cr | ₹645 Cr |
| Operating margin | 11.6% | 18.6% | 21.4% | 25.1% |
| Interest | ₹68 Cr | ₹98 Cr | ₹89 Cr | ₹82 Cr |
| Depreciation | ₹109 Cr | ₹124 Cr | ₹131 Cr | ₹144 Cr |
| Net profit | ₹21 Cr | ₹96 Cr | ₹184 Cr | ₹317 Cr |
| Net margin | 1.3% | 5.5% | 8.8% | 12.4% |
| Cash from operations | ₹49 Cr | ₹354 Cr | ₹281 Cr | ₹550 Cr |
| Free cash flow | ₹-91 Cr | ₹212 Cr | ₹-17 Cr | ₹230 Cr |
| ROCE | 6.0% | 12.0% | 16.0% | 22.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹39 Cr | ₹39 Cr | ₹39 Cr | ₹39 Cr | ₹39 Cr | ₹39 Cr |
| Reserves | ₹683 Cr | ₹773 Cr | ₹790 Cr | ₹885 Cr | ₹1.2k Cr | ₹1.4k Cr |
| Borrowings | ₹537 Cr | ₹933 Cr | ₹1.1k Cr | ₹1.0k Cr | ₹1.1k Cr | ₹1.0k Cr |
| Other liabilities | ₹281 Cr | ₹431 Cr | ₹483 Cr | ₹410 Cr | ₹645 Cr | ₹736 Cr |
| Total liabilities | ₹1.5k Cr | ₹2.2k Cr | ₹2.4k Cr | ₹2.3k Cr | ₹3.0k Cr | ₹3.2k Cr |
| Fixed assets | ₹598 Cr | ₹704 Cr | ₹1.0k Cr | ₹1.0k Cr | ₹1.1k Cr | ₹1.2k Cr |
| Capital work in progress | ₹175 Cr | ₹373 Cr | ₹100 Cr | ₹99 Cr | ₹262 Cr | ₹314 Cr |
| Investments | ₹0 Cr | ₹12 Cr | ₹7 Cr | ₹40 Cr | ₹20 Cr | ₹54 Cr |
| Other assets | ₹768 Cr | ₹1.1k Cr | ₹1.3k Cr | ₹1.2k Cr | ₹1.6k Cr | ₹1.6k Cr |
| Total assets | ₹1.5k Cr | ₹2.2k Cr | ₹2.4k Cr | ₹2.3k Cr | ₹3.0k Cr | ₹3.2k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, promoters trimmed −9.29 pp while DIIs added +6.17 pp. The shareholder count grew 56% to 44,875.
- Promoters
- 60.6%
- FIIs
- 1.9%
- DIIs
- 10.1%
- Public
- 27.4%
Since Jun 2025
- Promoters −9.29 pp
- DIIs +6.17 pp
- Public +2.66 pp
How it drifted, 12 quarters
Over this window promoters fell from 74.0% to 60.6% — −13.4 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 74.0%, FIIs 1.0%, DIIs 3.4%, Public 21.6%.Dec '23: Promoters 74.0%, FIIs 1.0%, DIIs 3.4%, Public 21.6%.Mar '24: Promoters 74.0%, FIIs 0.6%, DIIs 3.4%, Public 21.9%.Jun '24: Promoters 74.0%, FIIs 0.5%, DIIs 2.8%, Public 22.6%.Sep '24: Promoters 74.0%, FIIs 0.4%, DIIs 2.5%, Public 23.0%.Dec '24: Promoters 74.0%, FIIs 0.5%, DIIs 2.1%, Public 23.4%.Mar '25: Promoters 74.0%, FIIs 0.4%, DIIs 1.9%, Public 23.6%.Jun '25: Promoters 69.9%, FIIs 1.5%, DIIs 3.9%, Public 24.7%.Sep '25: Promoters 69.9%, FIIs 1.3%, DIIs 4.5%, Public 24.2%.Dec '25: Promoters 60.6%, FIIs 1.6%, DIIs 10.3%, Public 27.5%.Mar '26: Promoters 60.6%, FIIs 1.4%, DIIs 10.7%, Public 27.4%.Jun '26: Promoters 60.6%, FIIs 1.9%, DIIs 10.1%, Public 27.4%.
Who is on the register
Named in the Jun 2026 filing
Every holder of Privi Speciality Chemicals Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Vivira Investment & Trading Pvt Ltd | 29.74% | unchanged |
| Moneymart Securities Pvt Ltd | 8.74% | unchanged |
| SBI Small Cap Fund Mutual fund | 8.21% | −0.72 pp |
| Mahesh P Babani | 6.62% | unchanged |
| Banbridge Limited | 5.07% | unchanged |
| Mahesh Purshottam Babani Huf | 4.59% | unchanged |
| Bhaktavatsala Rao Doppalapudi | 2.17% | unchanged |
| Vinay Kumar Rao Doppalapudi | 1.44% | unchanged |
| Bhartula Vjk Sharma | 1.38% | unchanged |
| Vijay Kumar Doppalapudi | 1.37% | unchanged |
| Premaleela Doppalapudi | 1.34% | unchanged |
| Jyoti Mahesh Babani | 1.00% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Mutual funds in PRIVISCL
Filings to Aug 2026
0 new, 0 added, 3 trimmed, 0 sold out — net −1.46 L shares (−4.6%).
- Held by funds
- ₹1.0k Cr
- 4 schemes
- Biggest holder
- SBI Smallcap Fund
- ₹660 Cr · 1.6% of that fund
| Scheme | Holding | Last month | Held since |
|---|---|---|---|
| SBI Smallcap Fund SBI Mutual Fund | ₹660 Cr | held | Dec '25 |
| SBI Children's Fund - Investment Plan (Erstwhile known as SBI Magnum Children's Benefit Fund- IP) SBI Mutual Fund | ₹199 Cr | −0.37 L | Jun '25 |
| SBI Multi Asset Allocation Fund SBI Mutual Fund | ₹122 Cr | −0.97 L | Jun '25 |
| SBI MNC Fund SBI Mutual Fund | ₹63 Cr | −0.12 L | Jul '25 |
HDFC, Nippon India and SBI schemes, from their monthly disclosures. Changes are counted in shares, so a price move never looks like buying or selling.
Mutual funds Aug 2026
0 added, 3 trimmed — net −1.46 L shares (−4.6%)
- Funds are sitting on
- +40%
- vs est. average cost
- Held by funds
- ₹1.0k Cr
- 4 schemes · ≈ 7.9% of the company
- Biggest holder
- SBI Smallcap Fund
- ₹660 Cr · 1.6% of that fund
- Longest holder
- SBI Children's Fund - Investment Plan (Erstwhile known as SBI Magnum Children's Benefit Fund- IP)
- 1y 3m · since Jun '25
Shares held by these funds +231%
Aug '23 31.53 L shares Jul '26
All earnings calls (6)
Read the Q1 FY27 call →Learn to analyse Privi Speciality Chemicals Limited
Guides on how to read this kind of business and the numbers that matter.